![](/img/cover-not-exists.png)
Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy
E. Cock, J. Hutton, P. Canney, J. J. Body, P. Barrett-Lee, M. P. Neary, G. LewisVolume:
13
Language:
english
Pages:
12
DOI:
10.1007/s00520-005-0828-1
Date:
December, 2005
File:
PDF, 200 KB
english, 2005